These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9112231)

  • 1. Antinuclear autoantibodies: probes for defining proteolytic events associated with apoptosis.
    Casiano CA; Tan EM
    Mol Biol Rep; 1996; 23(3-4):211-6. PubMed ID: 9112231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinuclear antibodies: diagnostic markers and clues to the basis of systemic autoimmunity.
    Tan EM
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S3-9. PubMed ID: 2456507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis.
    Casiano CA; Martin SJ; Green DR; Tan EM
    J Exp Med; 1996 Aug; 184(2):765-70. PubMed ID: 8760832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinuclear antibodies recognize cellular autoantigens driven by apoptosis.
    Ramírez-Sandoval R; Sánchez-Rodríguez SH; Herrera-van Oostdam D; Avalos-Díaz E; Herrera-Esparza R
    Joint Bone Spine; 2003 Jun; 70(3):187-94. PubMed ID: 12814761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity.
    Tan EM; Chan EK; Sullivan KF; Rubin RL
    Clin Immunol Immunopathol; 1988 May; 47(2):121-41. PubMed ID: 3280190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human autoimmune sera as molecular probes for the identification of an autoantigen kinase signaling pathway.
    Kamachi M; Le TM; Kim SJ; Geiger ME; Anderson P; Utz PJ
    J Exp Med; 2002 Nov; 196(9):1213-25. PubMed ID: 12417631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens: implications for systemic autoimmunity.
    Wu X; Molinaro C; Johnson N; Casiano CA
    Arthritis Rheum; 2001 Nov; 44(11):2642-52. PubMed ID: 11710720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in the understanding of antinuclear autoantibodies.
    Casiano CA; Tan EM
    Int Arch Allergy Immunol; 1996 Dec; 111(4):308-13. PubMed ID: 8957101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fate of the U1 snRNP autoantigen during apoptosis: implications for systemic autoimmunity.
    Malmegrim KC; Pruijn GJ; van Venrooij WJ
    Isr Med Assoc J; 2002 Sep; 4(9):706-12. PubMed ID: 12440236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-dsDNA in the pathogenesis of systemic lupus erythematosus.
    Bai Y; Tong Y; Liu Y; Hu H
    Clin Exp Immunol; 2018 Jan; 191(1):1-10. PubMed ID: 28836661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of apoptosis as mechanism supporting the induction of autoimmunity.
    Lorenz HM; Kalden JR
    Curr Rheumatol Rep; 2004 Aug; 6(4):249-51. PubMed ID: 15251070
    [No Abstract]   [Full Text] [Related]  

  • 12. The Role of Cell Death in the Pathogenesis of SLE: Is Pyroptosis the Missing Link?
    Magna M; Pisetsky DS
    Scand J Immunol; 2015 Sep; 82(3):218-24. PubMed ID: 26118732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinuclear antibodies: cause of disease or caused by disease?
    Smeenk RJ
    Rheumatology (Oxford); 2000 Jun; 39(6):581-4. PubMed ID: 10888701
    [No Abstract]   [Full Text] [Related]  

  • 14. What triggers anti-dsDNA antibodies?
    Herrmann M; Zoller OM; Hagenhofer M; Voll R; Kalden JR
    Mol Biol Rep; 1996; 23(3-4):265-7. PubMed ID: 9112239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinuclear antibodies defining autoimmunity pathways.
    Tan EM
    Arthritis Res Ther; 2014 Feb; 16(1):104. PubMed ID: 24517467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases.
    Nakamura RM; Tan EM
    Clin Lab Med; 1992 Mar; 12(1):1-23. PubMed ID: 1563236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle-associated autoantibodies: markers for autoimmunity and probes for molecular cell biology.
    Yeo JP; Toh BH
    Autoimmunity; 1994; 18(4):291-300. PubMed ID: 7858115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macromolecular substrates for the ICE-like proteases during apoptosis.
    Rosen A; Casciola-Rosen L
    J Cell Biochem; 1997 Jan; 64(1):50-4. PubMed ID: 9015754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microparticles in systemic Lupus Erythematosus.
    Nielsen CT
    Dan Med J; 2012 Nov; 59(11):B4548. PubMed ID: 23171755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of antinuclear antibodies in systemic lupus erythematosus and related diseases.
    Tan EM
    Adv Dent Res; 1996 Apr; 10(1):44-6. PubMed ID: 8934923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.